184 related articles for article (PubMed ID: 16129733)
1. Evidence for a secondary state of the human beta3-adrenoceptor.
Baker JG
Mol Pharmacol; 2005 Dec; 68(6):1645-55. PubMed ID: 16129733
[TBL] [Abstract][Full Text] [Related]
2. The beta3-adrenoceptor agonist 4-[[(Hexylamino)carbonyl]amino]-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]-phenyl]-benzenesulfonamide (L755507) and antagonist (S)-N-[4-[2-[[3-[3-(acetamidomethyl)phenoxy]-2-hydroxypropyl]amino]-ethyl]phenyl]benzenesulfonamide (L748337) activate different signaling pathways in Chinese hamster ovary-K1 cells stably expressing the human beta3-adrenoceptor.
Sato M; Hutchinson DS; Evans BA; Summers RJ
Mol Pharmacol; 2008 Nov; 74(5):1417-28. PubMed ID: 18684840
[TBL] [Abstract][Full Text] [Related]
3. GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog.
Hicks A; McCafferty GP; Riedel E; Aiyar N; Pullen M; Evans C; Luce TD; Coatney RW; Rivera GC; Westfall TD; Hieble JP
J Pharmacol Exp Ther; 2007 Oct; 323(1):202-9. PubMed ID: 17626794
[TBL] [Abstract][Full Text] [Related]
4. Functional domains of the mouse beta3-adrenoceptor associated with differential G protein coupling.
Sato M; Hutchinson DS; Bengtsson T; Floren A; Langel U; Horinouchi T; Evans BA; Summers RJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1354-61. PubMed ID: 16144970
[TBL] [Abstract][Full Text] [Related]
5. Site of action of beta-ligands at the human beta1-adrenoceptor.
Baker JG
J Pharmacol Exp Ther; 2005 Jun; 313(3):1163-71. PubMed ID: 15716385
[TBL] [Abstract][Full Text] [Related]
6. Lack of evidence that nebivolol is a β₃-adrenoceptor agonist.
Frazier EP; Michel-Reher MB; van Loenen P; Sand C; Schneider T; Peters SL; Michel MC
Eur J Pharmacol; 2011 Mar; 654(1):86-91. PubMed ID: 21172342
[TBL] [Abstract][Full Text] [Related]
7. The odd sibling: features of β3-adrenoceptor pharmacology.
Cernecka H; Sand C; Michel MC
Mol Pharmacol; 2014 Nov; 86(5):479-84. PubMed ID: 24890609
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
[TBL] [Abstract][Full Text] [Related]
9. Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: differences between second messenger and reporter gene responses.
Baker JG; Hall IP; Hill SJ
Mol Pharmacol; 2003 Sep; 64(3):679-88. PubMed ID: 12920204
[TBL] [Abstract][Full Text] [Related]
10. Identification of potent agonists acting at an endogenous atypical beta3-adrenoceptor state that modulate lipolysis in rodent fat cells.
Hamilton BS; Doods HN
Eur J Pharmacol; 2008 Feb; 580(1-2):55-62. PubMed ID: 18031735
[TBL] [Abstract][Full Text] [Related]
11. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Baker JG
Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
[TBL] [Abstract][Full Text] [Related]
12. Induction of beta3-adrenergic receptor functional expression following chronic stimulation with noradrenaline in neonatal rat cardiomyocytes.
Germack R; Dickenson JM
J Pharmacol Exp Ther; 2006 Jan; 316(1):392-402. PubMed ID: 16183708
[TBL] [Abstract][Full Text] [Related]
13. Further characterization of beta3-adrenoceptors in the guinea pig gastric fundus: stereoselectivity, beta-adrenoceptor alkylation, and structure-activity relationship.
Horinouchi T; Koike K
Can J Physiol Pharmacol; 2001 Dec; 79(12):985-95. PubMed ID: 11824942
[TBL] [Abstract][Full Text] [Related]
14. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mexiletine as an antagonist of beta-adrenoceptor in Chinese hamster ovary cells expressing cloned human beta-adrenoceptors.
Sakamoto K; Karikomi Y; Kubota Y; Nakahara T; Ishii K
Biochem Pharmacol; 2004 Mar; 67(5):815-22. PubMed ID: 15104234
[TBL] [Abstract][Full Text] [Related]
16. Beta3-adrenoceptor in the eel (Anguilla anguilla) heart: negative inotropy and NO-cGMP-dependent mechanism.
Imbrogno S; Angelone T; Adamo C; Pulerà E; Tota B; Cerra MC
J Exp Biol; 2006 Dec; 209(Pt 24):4966-73. PubMed ID: 17142685
[TBL] [Abstract][Full Text] [Related]
17. The new radioligand [(3)H]-L 748,337 differentially labels human and rat β3-adrenoceptors.
van Wieringen JP; Michel-Reher MB; Hatanaka T; Ueshima K; Michel MC
Eur J Pharmacol; 2013 Nov; 720(1-3):124-30. PubMed ID: 24183974
[TBL] [Abstract][Full Text] [Related]
18. 2-Amino-4-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridines: novel selective beta3-adrenoceptor agonists.
Zheng W; Nikulin VI; Konkar AA; Vansal SS; Shams G; Feller DR; Miller DD
J Med Chem; 1999 Jun; 42(12):2287-94. PubMed ID: 10377236
[TBL] [Abstract][Full Text] [Related]
19. Functional and molecular characterization of beta-adrenoceptors in the internal anal sphincter.
Rathi S; Kazerounian S; Banwait K; Schulz S; Waldman SA; Rattan S
J Pharmacol Exp Ther; 2003 May; 305(2):615-24. PubMed ID: 12606629
[TBL] [Abstract][Full Text] [Related]
20. Activation of beta2- and beta3-adrenergic receptors increases brain tryptophan.
Lenard NR; Gettys TW; Dunn AJ
J Pharmacol Exp Ther; 2003 May; 305(2):653-9. PubMed ID: 12606631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
